ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BGM vs HURA // EV/EBITDA & P/E VALUATION

BGM Group Ltd. (Class A) (NASDAQ) VS. TuHURA Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: BGM 3 — HURA 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BGM VS. HURA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BGM HURA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 16.60% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — -35.00% — TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -3.09% -21.10% +18.01 BGM /fcf-yield <GO>
Operating Margin -33.20% — — TIE /operating-margins <GO>
Net Profit Margin -52.60% — — TIE /net-margins <GO>
Revenue Growth (YoY) 51.10% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 1/9 +1.00 BGM /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 56.6 47.5 +9.16 BGM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $127.4M $131.3M -$3.9M HURA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BGM REV HURA REV BGM GROSS % HURA GROSS % BGM FCF HURA FCF
FY 2025 $37.9M $0 16.6% — -$3.9M -$27.7M
FY 2024 $25.1M $0 16.4% — $304.1K -$14.8M
FY 2023 $46.5M $0 — — $312.2K -$12.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BGM // BETA —
HURA // BETA —